Cases 1 - 10 of 29
AbbVie Inc. v. Hetero USA, Inc. et al
as 1:2024cv01254
Plaintiff:
AbbVie Inc.
Defendant:
Sun Pharmaceutical Industries, Ltd., Sandoz Inc., Hetero Labs Limited and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Hetero USA, Inc. et al
as 1:2024cv00924
Defendant:
Hoster Labs Private Limited, Hetero Labs Limited, Sun Pharmaceutical Industries, Ltd. and others
Plaintiff:
AbbVie Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ViiV Healthcare Company et al v. Hetero USA, Inc. et al
as 1:2024cv00657
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA, Inc.
Plaintiff:
ViiV Healthcare Company, Shionogi & Co., Ltd. and ViiV Healthcare UK (No. 3) Limited
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Azurity Pharmaceuticals, Inc. et al v. Hetero Labs Limited et al
as 1:2024cv00396
Plaintiff:
Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC and Takeda Pharmaceutical Company Limited
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Hetero Labs Limited et al
as 1:2024cv00151
Plaintiff:
AbbVie Inc.
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Hetero USA, Inc. et al
as 1:2023cv01332
Plaintiff:
AbbVie Inc.
Defendant:
Hetero USA, Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Hetero Labs Limited et al
as 1:2023cv00448
Plaintiff:
AbbVie Inc.
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Hetero USA Inc. et al
as 1:2023cv00048
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and others
Defendant:
Hetero USA Inc., Hetero Labs Limited Unit-V and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Aragon Pharmaceuticals, Inc. et al v. Hetero Labs Limited Unit V et al
as 1:2022cv00696
Plaintiff:
Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and others
Defendant:
Hetero Labs Limited Unit V and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
